FDA Authorizes Plasma Treatment for CODID-19

U.S. President Donald Trump speaks during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., on Sunday, August 23, 2020. Trump announced that the Food and Drug Administration (FDA) has issued emergency use authorization to treat COVID-19 patients with convalescent plasma. It has been used in trials for two months at the Mayo Clinic but some health officials say data is lacking for approval. Photo by Stefani Reynolds/UPI